Evidence map›Paper›PMID 33683579›Full record

ReviewCurrent nutrition reports2021

The Anti-cancer Effect of Olea europaea L. Products: a Review.

Chrystalla Antoniou, Jonathon Hull

Open access · hybridAbstract readReview
In one paragraph

Review in Current nutrition reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Cytotoxic Triterpenes from Argan Pulp (Molecules (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. In-Depth Analysis ofBiology · 2024
    Article
  5. The Role of Natural Products in Immunopharmacology.International journal of molecular sciences · 2024
    Article
  6. Article
  7. Article
  8. Encapsulation of Olive (Foods (Basel, Switzerland) · 2024
    Article
  9. Review
  10. Potential Therapeutic Properties ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. In-Silico Analysis of Phytocompounds ofMolecules (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Green Synthesis of Silver Nanoparticles UsingInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chrystalla AntoniouFaculty of Health and Life Sciences, University of the West of England, Coldharbour Lane, Bristol, BS16 1QY, UK.
Jonathon HullFaculty of Health and Life Sciences, University of the West of England, Coldharbour Lane, Bristol, BS16 1QY, UK. jonathon2.hull@uwe.ac.uk.ORCID http://orcid.org/0000-0003-0611-612X
University of the West of England · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe olive tree (Olea europaea L.) has featured as a significant part of medicinal history, used to treat a variety of ailments within folk medicine. The Mediterranean diet, which is rich in olive products, is testament to Olea europaeas positive effects on health, associated with reduced incidences of cancer and cardiovascular disease. This review aims to summarise the current literature regarding the therapeutic potential of Olea europaea products in cancer, detailing the possible compounds responsible for its chemotherapeutic effects. RECENT

findingsMuch of the existing research has focused on the use of cell culture models of disease, demonstrating Olea europaea extracts, and specific compounds within these extracts, have efficacy in a range of in vitro and in vivo cancer models. The source of Olea europaeas cytotoxicity is yet to be fully defined; however, compounds such as oleuropein and verbascoside have independent cytotoxic effects on animal models of cancer. Initial results from animal models are promising but need to be translated to a clinical setting. Treatments utilising these compounds are likely to be well tolerated and represent a promising direction for future research.

Indexed as

Antineoplastic AgentsOleaAnimalsMedicine, TraditionalPlant ExtractsPlant LeavesAntineoplastic AgentsPlant ExtractsCancerChemotherapeuticOlea europaeaOlive

Identifiers

PMID33683579
PMCPMC7979598
OpenAlexW3134776227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.